表紙
市場調査レポート

米国の自動微生物検査市場の新たなフロンティア:ビジネス面での課題、新規技術、競争環境

US Automated Microbiology Market New Frontiers, Business Challenges, Emerging Technologies, Competitive Landscape

発行 Venture Planning Group 商品コード 301407
出版日 ページ情報 英文 436 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=102.95円で換算しております。

Local License: 同一事業所内

Back to Top
米国の自動微生物検査市場の新たなフロンティア:ビジネス面での課題、新規技術、競争環境 US Automated Microbiology Market New Frontiers, Business Challenges, Emerging Technologies, Competitive Landscape
出版日: ページ情報: 英文 436 Pages
概要

当レポートでは、米国における自動微生物検査検査の関連市場の最新動向や今後の市場機会について分析し、全体的な市場規模や将来動向(今後5年間分)、現在の診断技術の概要と今後の技術進歩・活用の見通し、今後の市場機会および解決すべき課題、現在/将来の市場参入企業のプロファイルなどを調査して、その結果を概略以下の構成でお届けします。

第1章 イントロダクション

第2章 世界市場と技術概要

  • イントロダクション
    • 微生物診断装置の市場普及率への主な影響要因
    • 従来型の手法
    • 技術的課題
    • 自動化:検査所・患者への影響
  • 主な試料の種類
    • 尿
    • 滅菌流体:血液・血清・CSF(脳脊髄液)
    • 咽頭綿棒および気道分泌物
    • 生殖分泌物
    • 便
    • 膿瘍/創傷
    • 唾液
    • つば
  • 検査の用途
    • 微生物の同定(増幅方法、シーケンシング、マイクロアレイ/バイオチップ)
    • 薬剤(抗生物質)感受性
    • 尿スクリーニング
      • 測光
      • バイオルミネンス
      • 比色濾過
      • 酵素検出
      • 工学的検出
    • 血液培養
  • 主な微生物検査用自動/半自動装置
    • 多目的微生物検査装置
    • 専用微生物検査装置
    • 分子診断装置
    • 免疫診断装置
  • 新たな診断技術
    • 分子診断
    • モノクローナル抗体
    • 免疫学的検定
    • 差分光散乱
    • IT
    • 人工知能
    • リポソーム
    • フローサイトメトリ
    • クロマトグラフィ
    • 画像診断
    • ゲル微液滴
    • その他
  • 世界のビジネス環境
  • 世界市場の構造
  • 世界市場の規模と成長率

第3章 米国市場

  • ビジネス環境
  • 市場構造
  • 市場規模・成長率、主要サプライヤーの売上高・市場シェア

第4章 主要製品の開発機会

第5章 分散検査製品の設計基準

第6章 代替的な市場普及戦略

  • 内部開発
  • 共同事業協定
  • 大学との契約
  • 分散検査市場の流通戦略
    • マーケティングのアプローチ
    • 製品の複雑性
    • 顧客の選好
    • 既存のサプライヤー
    • 新規参入サプライヤー
    • 流通業者の主な種類
    • 市場の細分化

第7章 潜在的な市場参入障壁とリスク

  • 市場の成熟化
  • コスト抑制
  • 競争
  • 最先端技術とその限界
  • 特許保護
  • 規制による抑制
  • 分散検査市場の課題

第8章 競合企業の評価

  • Abbott
  • Affymetrix
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca/Nuvelo
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • bioMerieux
  • Bio-Rad
  • Biotest
  • Caliper
  • Cepheid
  • Decode
  • Diadexus
  • Diamedix
  • DiaSorin
  • 栄研化学
  • Enzo Biochem
  • Exact Sciences
  • 富士レビオ/Innogenetics
  • Hologic/Gen-Probe
  • Illumina
  • ID Biomedical/GSK
  • Kreatech
  • Li-Cor Biosciences
  • Lonza
  • Monogram Biosciences
  • Myriad Genetics
  • Nanogen/Elitech
  • Novartis Diagnostics/Grifols
  • Orchid CellMark
  • Ortho-Clinical Diagnostics
  • Proteome Sciences
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • Sierra Molecular
  • 島津製作所
  • タカラバイオ
  • Tecan
  • Thermo Fisher/Life Technologies
  • Wallac/PE
  • 和光純薬工業

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPAM19977

VPGMarketResearch.com's new report is an analysis of the major business opportunities emerging in the automated microbiology market during the next five years. The report examines key trends in the U.S. automated microbiology market; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment, profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

Rationale

The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests.

The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon.

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide.

This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology market, in evaluating emerging opportunities and developing effective business strategies.

Supplier Shares, Sales and Volume Forecasts

- Sales and market shares of major suppliers of microbiology products, by individual test.

- Five-year test volume and sales forecasts for over 100 microbiology assays.

- Test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy).

U.S. Market Overview

- Review of the market dynamics, trends, structure, size, growth and major suppliers.

- Estimated universe of laboratories performing microbiology testing.

- Specimen, test volume and sales forecasts.

Business Opportunities and Strategic Recommendations

- Emerging opportunities for new analyzers, reagents kits, IT and other products with significant market appeal during the next five years.

- Design criteria for decentralized testing products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Specimen Types

- Urine Sterile Fluids: Blood, Serum, CSF Throat Swabs, Respiratory Secretions Genital Secretions Stool Abscess/Wound Sputum Saliva

Applications

- Microbial Identification Antibiotic Susceptibility Urine Screening Blood Cultures

Review of Major Automated Systems

- Review of major automated molecular diagnostic, multipurpose, specialized, microbial identification, antibiotic susceptibility, blood culture, urine screening, and immunodiagnostic analyzers.

- The report features analyzers manufactured by Abbott, Alifax, Anagen, BD, Beckman Coulter/Danaher, Biochem, Biolog, bioMerieux, Bio-Rad, Biotrol, Cepheid, Curetis, GenMark, Hologic/Gen-Probe, HTG, Iris, J&J, Labsystems, Life Technologies, MiDI, Olympus, Qiagen, Roche, Siemens, Sy-Lab, Sysmex, Tecan, Thermo Fisher, Tosoh.

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia and others.

Technology Assessment

- Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for the microbiology market.

- Global listings of companies developing or marketing microbiology products by individual test.

Competitive Strategies

- Strategic assessments of major suppliers and start-up firms developing innovative technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements, and new products in R&D.

The companies analyzed in the report include:

  • Abbott
  • Affymetrix
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca Biopharma
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • bioMerieux
  • Bio-Rad
  • Biotest
  • CellMark Forensics/LabCorp
  • Cepheid
  • Decode Genetics
  • Diadexus
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • Elitech Group
  • Enzo Biochem
  • Exact Sciences
  • Fujirebio
  • Grifols
  • Hologic/Gen-Probe
  • ID Biomedical/GSK
  • Illumina
  • Kreatech/Leica
  • Li-Cor Biosciences
  • Lonza
  • Monogram Biosciences
  • Myriad Genetics
  • Ortho-Clinical Diagnostics
  • Perkin Elmer/Caliper Life Sciences
  • Proteome Sciences
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Shimadzu
  • Siemens
  • Sierra Molecular
  • Takara Bio
  • Tecan
  • Thermo Fisher
  • Wallac/PE
  • Wako

Contains 436 pages and 94 tables

Table of Contents

I. Introduction

II. Worldwide Market and Technology Overview

  • A. Introduction
    • 1. Major Factors Affecting Market Penetration of Microbiology Instrumentation
    • 2. Traditional Practices
    • 3. Technological Challenges
    • 4. Automation: Impact on the Microbiology Laboratory and the Patient
  • B. Major Specimen Types
    • 1. Urine
    • 2. Sterile Fluids: Blood, Serum, and CSF
    • 3. Throat Swabs and Respiratory Secretions
    • 4. Genital Secretions
    • 5. Stool
    • 6. Abscess/Wound
    • 7. Sputum
    • 8. Saliva
  • C. Test Applications
    • 1. Microbial Identification
    • 2. Antibiotic Susceptibility
    • 3. Urine Screening
      • a. Photometry
      • b. Bioluminescence
      • c. Colorimetric Filtration
      • d. Enzymatic Detection
      • e. Optical Detection
    • 4. Blood Cultures
  • D. Major Microbiology Automated and Semiautomated Systems
    • 1. Multiple Purpose Microbiology Systems
    • 2. Specialized Microbiology Systems
    • 3. Molecular Diagnostic Systems
    • 4. Immunodiagnostic Systems
  • E. Emerging Diagnostic Technologies
    • 1. Molecular Diagnostics (Amplification Methods, Sequencing, Microarrays/Biochips)
      • a. DNA Sequencing
        • Introduction
        • Sequencing Methods
        • Autoradiography
        • The Human Genome Project
        • Sequencing Automation
        • Image Scanners
        • Fluorescent Detection
        • Gene Profiling
        • Gene Expression
        • Polymorphism Screening
        • Protein Interaction Networks
      • b. DNA And RNA Probe Technology
        • Basic Principles
        • Probe Preparation
        • The DNA Probe Test
          • Sample Preparation
          • Hybridization
          • Separation
          • Detection/Measurement
        • Test Formats
          • Filter Hybridization
          • Southern Blot
          • Northern Blot
          • In Situ Hybridization
          • Others
        • Labeling Techniques
        • Amplification Methods
          • Polymerase Chain Reaction
            • Temperature Cyclers
            • PCR Variations
              • Immuno-PCR
              • QC-PCR
              • DAP-PCR
          • Strand Displacement Activation
          • TMA
          • Ligase Chain Reaction
          • Branched DNA
            • Hybridization Protection Assay
          • Nucleic-Acid Sequence-Based Amplification
          • Self-Sustained Sequence Replicase
          • Others
            • Ampliprobe
            • CAR
            • CAS
            • CPT
            • Dendritic Polymer Technology
            • ISO-CR
            • LAT
            • Probe
            • RAMP
            • Repair Chain Reaction
            • Rolling Circles
            • Sequence Independent Gene Amplification
            • Sequence Initiation Reaction
            • SISPA
            • Solid Phase Amplification
      • c. Detection Technologies
        • Radioactive Methods
          • Overview
          • Major Isotopes
            • P-32
            • S-35
            • H-3
            • I-125
        • Non-Isotopic Methods
          • Enzymatic Labels
          • Chemical Labeling
            • Indirect Chemical Labeling
            • Direct Chemical Labeling
          • Fluorescence
          • Chemiluminescence
          • Electrical Conductivity
      • d. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip
        • Liquid Transportation and Mixing
        • Separation
        • Reaction
      • Detection
    • 2. Monoclonal Antibodies
    • 3. Immunoassays
    • 4. Differential Light Scattering
    • 5. Information Technology
    • 6. Artificial Intelligence
    • 7. Liposomes
    • 8. Flow Cytometry
    • 9. Chromatography
    • 10. Diagnostic Imaging
    • 11. Gel Microdroplets
    • 12. Other

III. U.S.

  • A. Business Environment
  • B. Market Structure
  • C. Market Size, Growth and Major Supplier Sales and Market Shares

IV. Major Product Development Opportunities

V. Design Criteria for Decentralized Testing Products

VI. Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product Complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types of Distributors
    • 7. Market Segmentation

VII. Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

VIII. Competitive Assessments

  • Abbott
  • Affymetrix
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca/Nuvelo
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • bioMerieux
  • Bio-Rad
  • Biotest
  • Caliper
  • Cepheid
  • Decode
  • Diadexus
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • Enzo Biochem
  • Exact Sciences
  • Fujirebio/Innogenetics
  • Hologic/Gen-Probe
  • Illumina
  • ID Biomedical/GSK
  • Kreatech
  • Li-Cor Biosciences
  • Lonza
  • Monogram Biosciences
  • Myriad Genetics
  • Nanogen/Elitech
  • Novartis Diagnostics/Grifols
  • Orchid CellMark
  • Ortho-Clinical Diagnostics
  • Proteome Sciences
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • Sierra Molecular
  • Shimadzu
  • Takara Bio
  • Tecan
  • Thermo Fisher/Life Technologies
  • Wallac/PE
  • Wako

List of Tables

  • Major Companies Developing or Marketing AIDS Tests
  • Major Companies Developing or Marketing Adenovirus Tests
  • Major Companies Developing or Marketing Bartonella Tests
  • Major Companies Developing or Marketing Campylobacter Tests
  • Major Companies Developing or Marketing Candida Tests
  • Major Companies Developing or Marketing Chlamydia Tests
  • Major Companies Developing or Marketing Clostridium Tests
  • Major Companies Developing or Marketing Coronavirus Tests
  • Major Companies Developing or Marketing Cryptosporidium Tests
  • Major Companies Developing or Marketing CMV Tests
  • Major Companies Developing or Marketing Echovirus Tests
  • Major Companies Developing or Marketing Enterovirus Tests
  • Major Companies Developing or Marketing EBV Tests
  • Major Companies Developing or Marketing Giardia Tests
  • Major Companies Developing or Marketing Gonorrhea Tests
  • Major Companies Developing or Marketing Hantavirus Tests
  • Major Companies Developing or Marketing Helicobacter Pylori Tests
  • Major Companies Developing or Marketing Hepatitis Tests
  • Major Companies Developing or Marketing Herpes Tests
  • Major Companies Developing or Marketing Influenza Tests
  • Major Companies Developing or Marketing Legionella Tests
  • Major Companies Developing or Marketing Lyme Disease Tests
  • Major Companies Developing or Marketing Lymphogranuloma Tests
  • Major Companies Developing or Marketing Malaria Tests
  • Major Companies Developing or Marketing Measles Tests
  • Major Companies Developing or Marketing Meningitis Tests
  • Major Companies Developing or Marketing Microsporidium Tests
  • Major Companies Developing or Marketing Mononucleosis Tests
  • Major Companies Developing or Marketing Mumps Tests
  • Major Companies Developing or Marketing Mycoplasma Tests
  • Major Companies Developing or Marketing Papilloma Virus Tests
  • Major Companies Developing or Marketing Parvovirus Tests
  • Major Companies Developing or Marketing Pneumonia Tests
  • Major Companies Developing or Marketing RSV Tests
  • Major Companies Developing or Marketing Rotavirus Tests
  • Major Companies Developing or Marketing Rubella Tests
  • Major Companies Developing or Marketing Salmonella Tests
  • Major Companies Developing or Marketing Septicemia Tests
  • Major Companies Developing or Marketing Shigella Tests
  • Major Companies Developing or Marketing Staphylococci Tests
  • Major Companies Developing or Marketing Streptococci Tests
  • Major Companies Developing or Marketing Syphilis Tests
  • Major Companies Developing or Marketing Toxoplasmosis Tests
  • Major Companies Developing or Marketing Trichomonas Tests
  • Major Companies Developing or Marketing Tuberculosis Tests
  • Major Companies Developing or Marketing West Nile Tests
  • Major Companies Developing or Marketing Yersinia Tests
  • U.S.A. Laboratories Performing Microbiology Tests by Market Segment
  • U.S.A. Hospital Laboratories Performing Microbiology Tests by Bed Size
  • U.S.A. Commercial/Private Laboratories Performing Microbiology Tests by Annual Test Volume
  • U.S.A. All Market Segments Microbiology Specimen Volume
  • U.S.A. Hospital Laboratories Microbiology Specimen Volume
  • U.S.A. Physician Offices/Group Practices Microbiology Specimen Volume
  • U.S.A. Public Health Laboratories Microbiology Specimen Volume
  • U.S.A. Commercial/Private Laboratories Microbiology Specimen Volume
  • U.S.A. Microbiology Test Volume by Market Segment
  • U.S.A. Microbiology Test Volume by Application
  • U.S.A. Microbial Identification Test Volume by Market Segment
  • U.S.A. Urine Screening Test Volume by Market Segment
  • U.S.A. Blood Culture Test Volume by Market Segment
  • U.S.A. Antibiotic Susceptibility Test Volume by Market Segment
  • U.S.A. Microbiology Consumables Market by Application
  • U.S.A. Microbiology Consumables Market by Market Segment
  • U.S.A. Microbial Identification Consumables Sales by Market Segment
  • U.S.A. Antibiotic Susceptibility Consumables Sales by Market Segment
  • U.S.A. Blood Culture Consumables Sales by Market Segment
  • U.S.A. Urine Screening Consumables Sales by Market Segment
  • U.S.A. All Market Segments Infectious Disease Test Volume Forecast by Assay
  • U.S.A. All Market Segments Infectious Disease Diagnostics Market Forecast by Test
  • U.S.A. Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • U.S.A. Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • U.S.A. HIV/AIDS Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. HIV/Hepatitis Blood Screening NAT Market Diagnostics Sales by Major Supplier
  • U.S.A. Adenovirus Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Campylobacter Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Candida Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Chancroid Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Chlamydia Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. CMV Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Cryptosporidium Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Echovirus Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Enterovirus Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. EBV Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Giardia Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Gonorrhea Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Helicobacter Pylori Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Hepatitis Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Hepatitis C Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Herpes Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Influenza Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Legionella Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Lyme Disease Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Measles Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Meningitis Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Mononucleosis Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Mumps Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Mycoplasma Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Pneumonia Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Rabies Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. RSV Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Rotavirus Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Rubella Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Salmonella Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Septicemia Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Shigella Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Streptococci Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Syphilis Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Tuberculosis Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Molecular Diagnostics Market Sales and Shares of Major Suppliers
Back to Top